Jonathan Piazza

Chief Financial Officer, Silverback Therapeutics.

Companies

Silverback TherapeuticsChief financial officer Dec 3, 2020 to May 4, 2022¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Silverback Therapeutics SPRY69,225 shares²$279.7K at $4.04May 2, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

May 2, 2022Granted 43,691 shares of Silverback Therapeutics²
Feb 1, 2022Granted 11,250 shares of Silverback Therapeutics³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARSilverback Therapeutics, Chief financial officer
2
SEC EDGARSilverback Therapeutics shares after the filing of May 2, 2022
3
SEC EDGARForm 4 filed Feb 2, 2022